University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
+$5.24M |
| 2 |
Select Water Solutions
WTTR
|
+$4.19M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$323K |
| 4 |
Home Depot
HD
|
+$305K |
| 5 |
PepsiCo
PEP
|
+$275K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
|
+$14.1M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$4.26M |
| 3 |
Vir Biotechnology
VIR
|
+$2.51M |
| 4 |
ExxonMobil
XOM
|
+$874K |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$514K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.26% |
| 2 | Technology | 4.97% |
| 3 | Energy | 1.95% |
| 4 | Financials | 0.27% |
| 5 | Consumer Discretionary | 0.23% |
Similar funds
University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q4 2022 Portfolio in Review
As of Q4 2022, University of Texas/Texas AM Investment Management Co (UTIMCO) held 77 positions worth $266M, down 0.43% from $267M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
University of Texas/Texas AM Investment Management Co (UTIMCO) withdrew a net $8.73M in Q4 2022, closing 25 positions and reducing 3 holdings. Its most notable exit was Vir Biotechnology, an estimated $2.51M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 5.3% of assets, down from 8.2% a quarter earlier, followed by Technology and Energy.
Against the trend, University of Texas/Texas AM Investment Management Co (UTIMCO) opened a new position in Select Water Solutions worth $4.6M.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q4 2022 buy was Select Water Solutions: 497,816 shares worth $4.6M.
- University of Texas/Texas AM Investment Management Co (UTIMCO) added most to HashiCorp, Inc. Class A Common Stock in Q4 2022, an estimated $5.24M increase.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q4 2022 reduction was JPMorgan BetaBuilders MSCI US REIT ETF, cutting an estimated $14.1M.
- University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited Vir Biotechnology in Q4 2022, selling an estimated $2.51M.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 98% of its $266M portfolio in Q4 2022.
- University of Texas/Texas AM Investment Management Co (UTIMCO) opened 36 new positions and closed 25 in Q4 2022.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value fell 0.43% quarter-over-quarter to $266M.
Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q4 2022, filed 14 Feb 2023.